Arkolith/Insider Trading/RGNX/Form 4

Pakola Steve

Chief Medical OfficerREGENXBIO Inc. (RGNX) · full profile →Form 4 · filed Jan 6, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2025Tax withholding(F)14K$7.73$107K152K
Jan 2, 2025Grant(A)64K—$0216K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 2, 2025Grant(A)104K—$0104K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-000190) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML